Fjarde AP Fonden Fourth Swedish National Pension Fund Sells 8,100 Shares of Cardinal Health, Inc. $CAH

Fjarde AP Fonden Fourth Swedish National Pension Fund decreased its stake in Cardinal Health, Inc. (NYSE:CAHFree Report) by 11.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 63,800 shares of the company’s stock after selling 8,100 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Cardinal Health were worth $13,111,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CAH. Versor Investments LP bought a new stake in shares of Cardinal Health in the third quarter valued at $2,090,000. Nordea Investment Management AB grew its stake in shares of Cardinal Health by 328.3% during the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after acquiring an additional 494,731 shares during the period. Candriam S.C.A. grew its stake in shares of Cardinal Health by 10.8% during the 3rd quarter. Candriam S.C.A. now owns 196,163 shares of the company’s stock worth $30,790,000 after acquiring an additional 19,155 shares during the period. Victory Capital Management Inc. grew its stake in shares of Cardinal Health by 44.9% during the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock worth $352,165,000 after acquiring an additional 707,495 shares during the period. Finally, Procyon Advisors LLC grew its stake in shares of Cardinal Health by 78.7% during the 4th quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock worth $3,499,000 after acquiring an additional 7,499 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CAH has been the subject of several research reports. Evercore cut their price target on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. Wells Fargo & Company lowered their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. JPMorgan Chase & Co. dropped their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research note on Monday, May 4th. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Sunday. Finally, Zacks Research upgraded shares of Cardinal Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $241.80.

Read Our Latest Report on CAH

Cardinal Health Stock Up 2.0%

NYSE:CAH opened at $205.79 on Friday. The stock has a market cap of $48.20 billion, a P/E ratio of 31.47, a PEG ratio of 1.12 and a beta of 0.52. The business’s 50-day moving average price is $202.53 and its two-hundred day moving average price is $208.57. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $233.60.

Cardinal Health (NYSE:CAHGet Free Report) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.Cardinal Health’s revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts expect that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is currently 31.19%.

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Read More

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.